A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia
Conditions
Waldenström's Macroglobulinemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Sun Yat Sen University Cancer Center, Guangzhou, Guangdong, China
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Affiliated Hospital of Hebei University, Baoding, Hebei, China
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Yichang Central Peoples Hospital, Yichang, Hubei, China
Xiangya Hospital of Central South University, Changsha, Hunan, China
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Study leads
Study Director
BeiGene